ATE263237T1 - Effizientes verfahren zum auffinden von genfunktionen mittels bibliotheken zur funktionellen genomanwendung - Google Patents
Effizientes verfahren zum auffinden von genfunktionen mittels bibliotheken zur funktionellen genomanwendungInfo
- Publication number
- ATE263237T1 ATE263237T1 AT99201866T AT99201866T ATE263237T1 AT E263237 T1 ATE263237 T1 AT E263237T1 AT 99201866 T AT99201866 T AT 99201866T AT 99201866 T AT99201866 T AT 99201866T AT E263237 T1 ATE263237 T1 AT E263237T1
- Authority
- AT
- Austria
- Prior art keywords
- libraries
- efficient method
- nucleic acids
- gene functions
- sample nucleic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/097,239 US6413776B1 (en) | 1998-06-12 | 1998-06-12 | High throughput screening of gene function using adenoviral libraries for functional genomics applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE263237T1 true ATE263237T1 (de) | 2004-04-15 |
Family
ID=22262382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99201866T ATE263237T1 (de) | 1998-06-12 | 1999-06-11 | Effizientes verfahren zum auffinden von genfunktionen mittels bibliotheken zur funktionellen genomanwendung |
Country Status (10)
Country | Link |
---|---|
US (3) | US6413776B1 (de) |
EP (1) | EP1022335B1 (de) |
JP (1) | JP3672494B2 (de) |
AT (1) | ATE263237T1 (de) |
AU (1) | AU756605B2 (de) |
CA (1) | CA2301403C (de) |
DE (1) | DE69916005T2 (de) |
MX (1) | MXPA00012401A (de) |
NZ (1) | NZ508995A (de) |
WO (1) | WO1999064582A2 (de) |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766891A (en) * | 1994-12-19 | 1998-06-16 | Sloan-Kettering Institute For Cancer Research | Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
US6783980B2 (en) * | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
EP0833934B2 (de) * | 1995-06-15 | 2012-08-15 | Crucell Holland B.V. | Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie |
US7883872B2 (en) | 1996-10-10 | 2011-02-08 | Dyadic International (Usa), Inc. | Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
EP1025217B1 (de) * | 1997-10-24 | 2006-10-04 | Invitrogen Corporation | Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen |
WO1999051620A1 (en) * | 1998-04-03 | 1999-10-14 | Invitrogen Corporation | Libraries of expressible gene sequences |
US6670188B1 (en) * | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
EA005682B1 (ru) | 1998-10-06 | 2005-04-28 | Марк Аарон Эмалфарб | Трансформированные грибы, в частности рода chrysosporium, способные к синтезу гетерологичных полипептидов |
JP2002535003A (ja) * | 1999-01-29 | 2002-10-22 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | アポトーシスを誘導するdna配列の単離方法及び検出システム |
US6642052B2 (en) * | 1999-02-25 | 2003-11-04 | National Research Council Of Canada | Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
AU2368201A (en) * | 1999-12-23 | 2001-07-09 | Xantos Biomedicine Ag | Screening method for nucleic acids |
JP2003521934A (ja) | 2000-02-09 | 2003-07-22 | ジェンベク、インコーポレイティッド | ウイルスベクターライブラリーの製造および使用方法 |
US7078501B2 (en) | 2000-02-25 | 2006-07-18 | Invitrogen Corporation | Topoisomerase linker-mediated amplification methods |
US7216113B1 (en) * | 2000-03-24 | 2007-05-08 | Symyx Technologies, Inc. | Remote Execution of Materials Library Designs |
KR20020026456A (ko) | 2000-04-13 | 2002-04-10 | 에말파브 마크 아론 | 사상균에서 발현된 dna 라이브러리의 고산출량 스크리닝 |
WO2003036265A2 (en) * | 2001-10-26 | 2003-05-01 | Virtual Arrays, Inc. | Assay systems with adjustable fluid communication |
AU2001252766A1 (en) * | 2000-04-26 | 2001-11-07 | Crucell Holland B.V. | Adenovirus vectors with knobless fibers, and their uses |
AU8835601A (en) * | 2000-08-21 | 2002-03-04 | Invitrogen Corp | Methods and reagents for molecular cloning |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
US20090118139A1 (en) * | 2000-11-07 | 2009-05-07 | Caliper Life Sciences, Inc. | Microfluidic method and system for enzyme inhibition activity screening |
US20060008817A1 (en) * | 2000-12-08 | 2006-01-12 | Invitrogen Corporation | Methods and compositions for generating recombinant nucleic acid molecules |
NZ526194A (en) * | 2000-12-08 | 2004-10-29 | Invitrogen Corp | Methods of covalently linking, in one or both strands, two or more double stranded nucleotide sequences using one or more topoisomerases |
EP1227157A1 (de) * | 2001-01-19 | 2002-07-31 | Galapagos Genomics B.V. | Swap/Gegenselektion: eine schnelles Klonierungsverfahren |
DE60235161D1 (de) * | 2001-01-25 | 2010-03-11 | Virxsys Corp | Methoden und zusammensetzungen zur identifikation von gen-funktion |
WO2002070744A2 (en) * | 2001-03-07 | 2002-09-12 | Galapagos Genomics B.V. | Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
US20040132008A1 (en) * | 2002-04-30 | 2004-07-08 | Doranz Benjamin J | Elucidation of gene function |
EP1256803A1 (de) | 2001-05-07 | 2002-11-13 | Crucell Holland B.V. | Verfahren zur Identifizierung von antiviralen Verbindungen |
JP2004537047A (ja) * | 2001-06-14 | 2004-12-09 | アナディーズ ファーマスーティカルズ,アイエヌシー. | 標的分子のリガンドをスクリーニングする方法 |
EP1273667A1 (de) * | 2001-07-04 | 2003-01-08 | Galapagos Genomics N.V. | Hochdurchsatzidentifizierung von Angiogenese Modulatoren |
KR20040022449A (ko) | 2001-07-12 | 2004-03-12 | 유니버시티 오브 매사추세츠 | 유전자 불활성화를 매개하는 소형 간섭 rna의 생체내제조 |
WO2003014346A2 (de) * | 2001-08-10 | 2003-02-20 | Xantos Biomedicine Ag | Hochdurchsatz dna-isolierung und -transfektion zur analyse der funktion von genen bzw. genprodukten |
JP2005503792A (ja) * | 2001-08-22 | 2005-02-10 | ガラパゴス・ジェノミックス・ナムローゼ・フェンノートシャップ | ハイ・スループット・スクリーニングにおいて同定される骨の恒常性のモジュレーター |
US7647184B2 (en) | 2001-08-27 | 2010-01-12 | Hanall Pharmaceuticals, Co. Ltd | High throughput directed evolution by rational mutagenesis |
US20030198627A1 (en) * | 2001-09-01 | 2003-10-23 | Gert-Jan Arts | siRNA knockout assay method and constructs |
US7381375B2 (en) | 2001-10-26 | 2008-06-03 | Millipore Corporation | Assay systems with adjustable fluid communication |
US20080187949A1 (en) * | 2001-10-26 | 2008-08-07 | Millipore Corporation | Multiplexed assays of cell migration |
JP2005514959A (ja) * | 2002-01-24 | 2005-05-26 | エコピア バイオサイエンシーズ インク | 微生物から二次代謝産物を同定するための方法、システム及び情報リポジトリ |
US20060121464A1 (en) * | 2002-06-07 | 2006-06-08 | Shophion Bioscience A/S | Screening methods |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
AU2003253992A1 (en) * | 2002-07-18 | 2004-02-09 | Robert P. Bennett | Viral vectors containing recombination sites |
CN101537180B (zh) | 2002-07-18 | 2016-02-10 | 莫鲁斯有限公司 | 抗体混合物的重组生产 |
AU2003263552A1 (en) | 2002-09-09 | 2004-03-29 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
JP4287633B2 (ja) * | 2002-09-18 | 2009-07-01 | 独立行政法人科学技術振興機構 | オルガネラ局在タンパク質の解析方法と解析材料 |
AU2003288273A1 (en) | 2002-10-23 | 2004-05-13 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
US20080153083A1 (en) | 2003-10-23 | 2008-06-26 | Crucell Holland B.V. | Settings for recombinant adenoviral-based vaccines |
US20080207465A1 (en) * | 2002-10-28 | 2008-08-28 | Millipore Corporation | Assay systems with adjustable fluid communication |
EP1566436A4 (de) * | 2002-11-21 | 2006-04-19 | Genomidea Inc | Verfahren zur isolierung von nukleinsäure mit erwünschter funktioneller eigenschaft und kit dafür |
NZ539813A (en) | 2002-12-17 | 2008-04-30 | Crucell Holland Bv | A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6 |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
ES2408582T3 (es) | 2003-05-30 | 2013-06-21 | Merus B.V. | Biblioteca de Fab para la preparación de una mezcla de anticuerpos |
WO2005001133A2 (en) * | 2003-06-03 | 2005-01-06 | Collateral Therapeutics, Inc. | Compositions and methods for high throughput construction and functional analysis of expression libraries |
US20050059083A1 (en) * | 2003-09-15 | 2005-03-17 | Becton Dickinson And Company | High throughput method to identify ligands for cell attachment |
US20050060100A1 (en) * | 2003-09-15 | 2005-03-17 | Becton Dickinson And Company | Computer software and algorithms for systems biologically linked to cellular phenotype |
JP2007512838A (ja) | 2003-12-01 | 2007-05-24 | インヴィトロジェン コーポレーション | 組換え部位を含む核酸分子およびその使用方法 |
AU2003300239A1 (en) * | 2003-12-29 | 2005-07-21 | Galapagos Genomics N.V. | Modulators of bone homeostasis identified in a high-throughput screen |
DK1737971T3 (da) | 2004-01-20 | 2017-11-13 | Merus Nv | Blandinger af bindingsproteiner |
WO2005118885A2 (en) * | 2004-04-15 | 2005-12-15 | Allied Biotech, Inc. | Methods and apparatus for detection of viral infection |
ES2353604T3 (es) | 2004-04-20 | 2011-03-03 | Galapagos N.V. | Métodos, composiciones y ensayos de compuestos para inhibir la producción de proteína beta-amiloide. |
GB0410105D0 (en) * | 2004-05-06 | 2004-06-09 | Amersham Biosciences Uk Ltd | Method for characterising compounds |
EP2256198A1 (de) | 2004-06-14 | 2010-12-01 | Galapagos N.V. | Identifizierungsverfahren und Verbindungen für die Behandlung degenerativer und entzündlicher Erkrankungen |
US20070004658A1 (en) | 2004-06-21 | 2007-01-04 | Nick Vandeghinste | Method and means for treatment of osteoarthritis |
US7485468B2 (en) | 2004-10-15 | 2009-02-03 | Galapagos Bv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
ES2679282T3 (es) | 2004-10-22 | 2018-08-23 | Revivicor Inc. | Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena |
US8680252B2 (en) | 2006-12-10 | 2014-03-25 | Dyadic International (Usa), Inc. | Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi |
JP2010538244A (ja) | 2007-06-20 | 2010-12-09 | ガラパゴス・ナムローゼ・フェンノートシャップ | 骨及び関節の変性疾患の治療に有用な分子標的及び化合物並びにその同定方法 |
EP2197893B1 (de) | 2007-09-07 | 2013-07-24 | Dyadic International, Inc. | Neue pilzenzyme |
CL2009001064A1 (es) | 2008-05-07 | 2009-10-09 | Galapagos Nv | Compuestos derivados de imidazol-pirazina o triazol-pirazina fusionados, inhibidores de mapkapk5; composicion farmaceutica que comprende dichos compuestos; y uso para preparar un medicamento destinado al tratamiento de inflamacion, especialmente en la artritis reumatoide. |
US8765376B2 (en) | 2008-09-11 | 2014-07-01 | Galapagos Nv | Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator |
ES2548377T3 (es) | 2008-10-27 | 2015-10-16 | Revivicor, Inc. | Ungulados inmunodeprimidos |
WO2011015572A1 (en) | 2009-08-03 | 2011-02-10 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
WO2011015573A1 (en) | 2009-08-03 | 2011-02-10 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
TW201120043A (en) | 2009-11-05 | 2011-06-16 | Galapagos Nv | Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
MY170927A (en) | 2011-11-28 | 2019-09-19 | Janssen Vaccines & Prevention Bv | Influenza virus vaccines and uses thereof |
PT2838918T (pt) | 2012-04-20 | 2019-08-23 | Merus Nv | Métodos e meios para a produção de moléculas heterrodiméricas do tipo ig |
WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
WO2015095811A2 (en) | 2013-12-20 | 2015-06-25 | The Board Institute Inc. | Combination therapy with neoantigen vaccine |
WO2016069591A2 (en) | 2014-10-27 | 2016-05-06 | The Broad Institute Inc. | Compositions, methods and use of synthetic lethal screening |
EP3757211A1 (de) | 2014-12-19 | 2020-12-30 | The Broad Institute, Inc. | Verfahren zur profilierung des t-zell-rezeptor-repertoirs |
WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
KR20180010229A (ko) | 2015-05-20 | 2018-01-30 | 더 브로드 인스티튜트, 인코퍼레이티드 | 공유 신생항원 |
AU2017254477A1 (en) | 2016-04-18 | 2018-11-01 | Jennifer G. ABELIN | Improved HLA epitope prediction |
US10707531B1 (en) | 2016-09-27 | 2020-07-07 | New Dominion Enterprises Inc. | All-inorganic solvents for electrolytes |
EP3336169A1 (de) * | 2016-12-15 | 2018-06-20 | Institut Polytechnique de Grenoble | Robotisches verfahren zum beschichten einer multiwellplatte durch einen mehrschichtigen polyelektrolytfilm |
EP3574116A1 (de) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids |
US11965892B2 (en) | 2017-02-12 | 2024-04-23 | Biontech Us Inc. | HLA-based methods and compositions and uses thereof |
US11793867B2 (en) | 2017-12-18 | 2023-10-24 | Biontech Us Inc. | Neoantigens and uses thereof |
US20210163926A1 (en) * | 2018-01-04 | 2021-06-03 | Arizona Board Of Regents On Behalf Of Arizona State University | Versatile amplicon single-cell droplet sequencing-based shotgun screening platform to accelerate functional genomics |
WO2020072700A1 (en) | 2018-10-02 | 2020-04-09 | Dana-Farber Cancer Institute, Inc. | Hla single allele lines |
WO2020131586A2 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Methods for identifying neoantigens |
CN114514319A (zh) | 2019-07-23 | 2022-05-17 | 詹森生物科技公司 | 用于生物制造的合成基因元件 |
AU2021280261A1 (en) | 2020-05-26 | 2023-01-19 | Dionis Therapeutics, Inc. | Nucleic acid artificial mini-proteome libraries |
WO2022132596A2 (en) | 2020-12-14 | 2022-06-23 | Biontech Us Inc. | Tissue-specific antigens for cancer immunotherapy |
WO2023076733A1 (en) | 2021-11-01 | 2023-05-04 | Dana-Farber Cancer Institute, Inc. | Biologically selected nucleic acid artificial mini-proteome libraries |
WO2024015892A1 (en) | 2022-07-13 | 2024-01-18 | The Broad Institute, Inc. | Hla-ii immunopeptidome methods and systems for antigen discovery |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497796A (en) | 1980-03-26 | 1985-02-05 | The Regents Of The University Of California | Gene transfer in intact mammals |
US4727028A (en) | 1981-06-22 | 1988-02-23 | Eli Lilly And Company | Recombinant DNA cloning vectors and the eukaryotic and prokaryotic transformants thereof |
US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
US5190931A (en) | 1983-10-20 | 1993-03-02 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5208149A (en) | 1983-10-20 | 1993-05-04 | The Research Foundation Of State University Of New York | Nucleic acid constructs containing stable stem and loop structures |
US4740463A (en) | 1984-04-13 | 1988-04-26 | Massachusetts Institute Of Technology | Methods and artificial genes for antagonizing the function of an oncogene |
US5518913A (en) | 1991-10-10 | 1996-05-21 | National Research Council Of Canada | High level recombinant protein production using conditional helper-free adenovirus vector |
CA2053187A1 (en) | 1991-10-10 | 1993-04-11 | National Research Council Of Canada | High level recombinant protein production using conditional helper-free adenovirus vector |
US6057427A (en) | 1991-11-20 | 2000-05-02 | Trustees Of Dartmouth College | Antibody to cytokine response gene 2(CR2) polypeptide |
FR2698880B1 (fr) | 1992-11-25 | 1995-02-24 | Inst Nat Sante Rech Med | Procédé de production de récepteurs T solubles, produits ainsi obtenus et leur utilisation dans des compositions diagnostiques ou thérapeutiques. |
EP0911413A3 (de) | 1992-12-03 | 2000-11-15 | Genzyme Corporation | Mindestadenovirus-Vector zur Gentherapie |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
FR2707664B1 (fr) | 1993-07-13 | 1995-09-29 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
SK282843B6 (sk) | 1993-07-13 | 2002-12-03 | Rhone-Poulenc Rorer S. A. | Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom |
US5401744A (en) | 1993-10-04 | 1995-03-28 | Bristol-Myers Squibb Company | Useful hemi-hydrate form of a cerebral function enhancing agent |
CA2117668C (en) | 1994-03-09 | 2005-08-09 | Izumu Saito | Recombinant adenovirus and process for producing the same |
EP0784690B1 (de) | 1994-06-10 | 2006-08-16 | Genvec, Inc. | Adenoviren-vektor systeme und zelllinien |
EP1369487A3 (de) | 1994-08-16 | 2004-04-07 | Crucell Holland B.V. | Von Adenovirus abgeleitete rekombinante Vektoren zur Verwendung in der Gentherapie |
US5856152A (en) * | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
FR2727689A1 (fr) | 1994-12-01 | 1996-06-07 | Transgene Sa | Nouveau procede de preparation d'un vecteur viral |
EP0833934B2 (de) | 1995-06-15 | 2012-08-15 | Crucell Holland B.V. | Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie |
US5837511A (en) | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
EP0927263A1 (de) * | 1996-01-05 | 1999-07-07 | Genetic Therapy, Inc. | Rekombinase-vermittelte herstellung adenoviraler vektoren |
US6455247B1 (en) | 1996-01-23 | 2002-09-24 | Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6197502B1 (en) | 1997-11-17 | 2001-03-06 | Cytos Biotechnology Ag | Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property |
WO1999032618A1 (en) | 1997-12-19 | 1999-07-01 | Strata Biosciences Incorporated | Non-bacterial cloning in delivery and expression of nucleic acids |
US6670188B1 (en) * | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
-
1998
- 1998-06-12 US US09/097,239 patent/US6413776B1/en not_active Expired - Lifetime
-
1999
- 1999-06-11 JP JP2000553572A patent/JP3672494B2/ja not_active Expired - Fee Related
- 1999-06-11 MX MXPA00012401A patent/MXPA00012401A/es active IP Right Grant
- 1999-06-11 WO PCT/NL1999/000367 patent/WO1999064582A2/en active IP Right Grant
- 1999-06-11 CA CA002301403A patent/CA2301403C/en not_active Expired - Lifetime
- 1999-06-11 NZ NZ508995A patent/NZ508995A/en not_active IP Right Cessation
- 1999-06-11 DE DE69916005T patent/DE69916005T2/de not_active Expired - Lifetime
- 1999-06-11 EP EP99201866A patent/EP1022335B1/de not_active Expired - Lifetime
- 1999-06-11 AU AU42947/99A patent/AU756605B2/en not_active Expired
- 1999-06-11 AT AT99201866T patent/ATE263237T1/de not_active IP Right Cessation
- 1999-07-21 US US09/358,036 patent/US6340595B1/en not_active Expired - Lifetime
-
2001
- 2001-12-21 US US10/036,949 patent/US7029848B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NZ508995A (en) | 2003-12-19 |
US6413776B1 (en) | 2002-07-02 |
EP1022335A1 (de) | 2000-07-26 |
CA2301403A1 (en) | 1999-12-16 |
JP3672494B2 (ja) | 2005-07-20 |
JP2002526031A (ja) | 2002-08-20 |
MXPA00012401A (es) | 2003-07-14 |
EP1022335B1 (de) | 2004-03-31 |
US7029848B2 (en) | 2006-04-18 |
AU756605B2 (en) | 2003-01-16 |
CA2301403C (en) | 2009-01-06 |
WO1999064582A2 (en) | 1999-12-16 |
DE69916005T2 (de) | 2004-09-09 |
US6340595B1 (en) | 2002-01-22 |
AU4294799A (en) | 1999-12-30 |
DE69916005D1 (de) | 2004-05-06 |
US20030027170A1 (en) | 2003-02-06 |
WO1999064582A3 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE263237T1 (de) | Effizientes verfahren zum auffinden von genfunktionen mittels bibliotheken zur funktionellen genomanwendung | |
DE60039037D1 (de) | Methode zur direkten sequenzierung von nukleinsäuren | |
WO2004083225A3 (fr) | Biopuces a sondes et leurs methodes d’utilisation | |
ATE118818T1 (de) | Verfahren zur herstellung synthetischer oligonukleotide, die spezifisch an bestimmungsstellen auf duplex-dna-molekülen binden durch formen eines kolinearen triplex, die synthetischen oligonukleotide und verfahren zu ihrer herstellung. | |
ATE118549T1 (de) | Verfahren zur synthese von ribonukleinsäure (rns). | |
ATE343586T1 (de) | Verfahren zur verwendung einer universellen bibliothek von peptid-nukleinsäuren zur optimierung der dns-hybridisierung | |
ATE141956T1 (de) | Verfahren zur vervielfältigung von nukleinsäuresequenzen | |
ATE356222T1 (de) | Massives parallelverfahren zur dekodierung von dna und rna | |
ATE545710T1 (de) | Verfahren zur vervielfältigung von nukleinsäuren | |
ATE377074T1 (de) | Methode zur bereitstellung von dna sequenzen | |
DE69636835D1 (de) | Verfahren zur verwendung der nukleotid-integrase zur spaltung von dna und zum einbau von nukleinsäuren | |
AU2003291610A1 (en) | Method to generate or determine nucleic acid tags corresponding to the terminal ends of dna molecules using sequences analysis of gene expression (terminal sage) | |
WO2000022171A3 (en) | Systems and methods for sequencing by hybridization | |
ATE278808T1 (de) | Verfahren zur charakterisierung von nukleinsäurefragmenten | |
ATE211180T1 (de) | Verfahren zur nicht-radioaktiven detektion von membran-gebundenen nukleinsäuren und testkit | |
ATE264865T1 (de) | Verfahren zum nachweis von biologischen materialen mit boviner herkunft, und oligonukleotiden die es gebraucht | |
ATE396281T1 (de) | Quantifizierungsverfahren für genetische modifikationen unter verwendung von standardmolekülen | |
DE59410068D1 (de) | Verfahren zur spezifischen Klonierung von Nukleinsäuren | |
ATE144557T1 (de) | Nucleinsäure-proben und verfahren zum nachweis von giardia lamblia | |
US6670120B1 (en) | Categorising nucleic acid | |
ATE382089T1 (de) | Verfahren zum herstellen eines rekombinanten proteins | |
ATE317123T1 (de) | Reaktiver träger zur bestimmung von dna fragmenten | |
PT778347E (pt) | Proteina ligante a atp e acidos nucleicos com propriedade de helicase e de atpase | |
WO2001040510A3 (de) | Dynamische sequenzierung durch hybridisierung | |
EP1182212A3 (de) | Ultraspiracle (USP)-Protein von Heliothis virescens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
EEFA | Change of the company name |